Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
83.1M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
51.6M
-
Shares change
-
-4.25M
-
Total reported value, excl. options
-
$31.5M
-
Value change
-
-$3.11M
-
Put/Call ratio
-
0
-
Number of buys
-
20
-
Number of sells
-
-32
-
Price
-
$0.61
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) as of Q2 2025
67 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.6M shares
of 83.1M outstanding shares and own 62.12% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (11.4M shares), TANG CAPITAL MANAGEMENT LLC (8.22M shares), RA CAPITAL MANAGEMENT, L.P. (7.54M shares), GOLDMAN SACHS GROUP INC (3.75M shares), VANGUARD GROUP INC (3.27M shares), Carlyle Group Inc. (2.95M shares), ACADIAN ASSET MANAGEMENT LLC (2.07M shares), Schonfeld Strategic Advisors LLC (1.88M shares), RENAISSANCE TECHNOLOGIES LLC (1.15M shares), and REGENERON PHARMACEUTICALS, INC. (968K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.